Literature DB >> 18823864

Surgical and obstetric outcomes in adults with sickle cell disease.

Soheir Adam1, Jude Jonassaint, Hillary Kruger, Melanie Kail, Eugene P Orringer, James R Eckman, Allison Ashley-Koch, Marilyn J Telen, Laura M De Castro.   

Abstract

BACKGROUND: Sickle cell disease patients are more likely than the general population to undergo surgery and usually do so at a younger age. Female sickle cell disease patients also have special gynecological and obstetric issues related to their disease.
METHODS: We collected data through standardized clinical report forms, patient interviews, and medical records from 509 adult sickle cell disease patients. Logistic regression was used to estimate the association between multiple variables and each of the surgery types. We also determined the prevalence and outcomes of pregnancy in 284 women with sickle cell disease in this population.
RESULTS: Almost 50% of patients aged 18-27 years had had a cholecystectomy. Mean corpuscular hemoglobin, total bilirubin, and lactate dehydrogenase were significantly higher in the postcholecystectomy group; 9.5% of 504 individuals had undergone splenectomy. Hematocrit, body mass index, and red blood cell count were significantly higher in the postsplenectomy group. Hip replacement had been performed in 9.2% of individuals, with the prevalence increasing as early as the fourth decade and continuing to increase through the sixth decade of life. A history of pregnancy was present in 190 women (67%). Of 410 pregnancies, only 53.9% resulted in live births, 16.6% were voluntarily terminated, and 29.5% were complicated by miscarriage, still birth, or ectopic implantation.
CONCLUSIONS: Sickle cell disease continues to have a strong effect on the mean age for common surgeries and impacts pregnancy outcomes. We conclude that this population has a unique surgical and obstetric history that should be further studied to provide insight into potentially more effective preventive approaches to end-organ damage.

Entities:  

Mesh:

Year:  2008        PMID: 18823864      PMCID: PMC3928637          DOI: 10.1016/j.amjmed.2008.04.040

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.

Authors:  K Y Fertrin; M B Melo; A M Assis; S T O Saad; F F Costa
Journal:  Clin Genet       Date:  2003-08       Impact factor: 4.438

Review 2.  Sickle cell disease and anesthesia.

Authors:  Paul G Firth; C Alvin Head
Journal:  Anesthesiology       Date:  2004-09       Impact factor: 7.892

3.  Obesity increases the likelihood of total joint replacement surgery among younger adults.

Authors:  S Harms; R Larson; A E Sahmoun; J R Beal
Journal:  Int Orthop       Date:  2006-05-11       Impact factor: 3.075

4.  The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.

Authors:  E P Vichinsky; L D Neumayr; C Haberkern; A N Earles; J Eckman; M Koshy; D M Black
Journal:  Am J Hematol       Date:  1999-11       Impact factor: 10.047

5.  Biliary surgery in sickle cell disease: the Jamaican experience.

Authors:  N D Duncan; A I Smith; A H McDonald; D I G Mitchell
Journal:  J R Coll Surg Edinb       Date:  2002-02

6.  Role of splenectomy in homozygous sickle cell disease in childhood.

Authors:  A M Emond; P Morais; S Venugopal; R G Carpenter; G R Serjeant
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

7.  Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases.

Authors:  M Koshy; S J Weiner; S T Miller; L A Sleeper; E Vichinsky; A K Brown; Y Khakoo; T R Kinney
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

8.  Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease.

Authors:  J A Smith; M Espeland; R Bellevue; D Bonds; A K Brown; M Koshy
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

9.  Relationships between body mass indices and surgical replacements of knee and hip joints.

Authors:  Aaron M Wendelboe; Kurt T Hegmann; Jeremy J Biggs; Chad M Cox; Aaron J Portmann; Jacob H Gildea; Lisa H Gren; Joseph L Lyon
Journal:  Am J Prev Med       Date:  2003-11       Impact factor: 5.043

10.  Body mass indices in patients with disabling hip osteoarthritis.

Authors:  Ray Marks; John P Allegrante
Journal:  Arthritis Res       Date:  2001-11-01
View more
  17 in total

1.  Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study.

Authors:  Nana O Wilson; Fatou K Ceesay; Jacqueline M Hibbert; Adel Driss; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Winston A Anderson; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 2.  Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Authors:  Rakhi P Naik; Michael B Streiff; Sophie Lanzkron
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

3.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-10

4.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2016-10

Review 5.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

Review 6.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

7.  Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.

Authors:  Riten Kumar; Joseph Stanek; Susan Creary; Amy Dunn; Sarah H O'Brien
Journal:  Blood Adv       Date:  2018-02-13

8.  Implications of radiologic-pathologic correlation for gallbladder disease in children and young adults with sickle cell disease.

Authors:  Heather I Gale; Bindu N Setty; Philippa G Sprinz; Gheorghe Doros; Don D Williams; Trevor C Morrison; Tyler A Kalajian; Powen Tu; Shankar N Mundluru; Manisha N Mehta; Ilse Castro-Aragon
Journal:  Emerg Radiol       Date:  2015-06-25

9.  Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement.

Authors:  Shital Kamble; Marilyn J Telen; Michaela A Dinan; Chelsea A Grussemeyer; Shelby D Reed
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

10.  Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.

Authors:  Michaela A Dinan; Chia-Hung Chou; Bradley G Hammill; Felicia L Graham; Kevin A Schulman; Marilyn J Telen; Shelby D Reed
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.